AU4841296A - Diagnosis of and compositions and methods for the treatment of disease - Google Patents

Diagnosis of and compositions and methods for the treatment of disease

Info

Publication number
AU4841296A
AU4841296A AU48412/96A AU4841296A AU4841296A AU 4841296 A AU4841296 A AU 4841296A AU 48412/96 A AU48412/96 A AU 48412/96A AU 4841296 A AU4841296 A AU 4841296A AU 4841296 A AU4841296 A AU 4841296A
Authority
AU
Australia
Prior art keywords
diagnosis
disease
compositions
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU48412/96A
Inventor
Henry Lawrence Butt
Richard Hugh Dunstan
Iven John Klineberg
Neil Roland Mcgregor
Timothy Kilgour ROBERTS
Mariann Zerbes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BIOSCREEN Pty Ltd
Original Assignee
BIOSCREEN Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BIOSCREEN Pty Ltd filed Critical BIOSCREEN Pty Ltd
Publication of AU4841296A publication Critical patent/AU4841296A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1271—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Micrococcaceae (F), e.g. Staphylococcus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU48412/96A 1995-02-15 1996-02-15 Diagnosis of and compositions and methods for the treatment of disease Abandoned AU4841296A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AUPN1150A AUPN115095A0 (en) 1995-02-15 1995-02-15 Analysis of and compositions and methods for the treatment of disease
AUPN1150 1995-02-15
PCT/IB1996/000222 WO1996025155A1 (en) 1995-02-15 1996-02-15 Diagnosis of and compositions and methods for the treatment of disease

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU65357/99A Division AU6535799A (en) 1995-02-15 1999-12-20 Diagnosis of and compositions and methods for the treatment of disease

Publications (1)

Publication Number Publication Date
AU4841296A true AU4841296A (en) 1996-09-04

Family

ID=3785508

Family Applications (2)

Application Number Title Priority Date Filing Date
AUPN1150A Abandoned AUPN115095A0 (en) 1995-02-15 1995-02-15 Analysis of and compositions and methods for the treatment of disease
AU48412/96A Abandoned AU4841296A (en) 1995-02-15 1996-02-15 Diagnosis of and compositions and methods for the treatment of disease

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AUPN1150A Abandoned AUPN115095A0 (en) 1995-02-15 1995-02-15 Analysis of and compositions and methods for the treatment of disease

Country Status (2)

Country Link
AU (2) AUPN115095A0 (en)
WO (1) WO1996025155A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19548221C1 (en) * 1995-12-22 1997-05-15 Biotest Pharma Gmbh Oral use of immunoglobulin preparations for the treatment and prophylaxis of chronic pain
SE9604844D0 (en) * 1996-12-30 1996-12-30 Carl Gerhard Gottfries Agents for the therapeutic treatment of fibromyalgia and chronic fatigue syndrome
SE523136C2 (en) * 1999-12-21 2004-03-30 Gottfriesmottagningen Ab Use of staphylococcal bacteria in the treatment of irritable bowel syndrome
DE102011006809A1 (en) 2011-04-05 2012-10-11 Freistaat Bayern vertreten durch die Julius-Maximilians-Universität Würzburg Use of an agent of antibodies and / or insulin-like growth factor antagonists
DE102011006781A1 (en) * 2011-04-05 2012-10-11 Mat-Malta Advanced Technologies Limited Antibody product comprising n specific antibodies

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR6901M (en) * 1967-06-23 1969-04-28
DE3034975C2 (en) * 1980-09-17 1986-11-27 Dr. Karl Thomae Gmbh, 7950 Biberach Drug combination used to treat infectious respiratory diseases
US4532206A (en) * 1982-07-19 1985-07-30 Vitek Systems, Inc. β-Streptococcus selective medium
JPS60218396A (en) * 1984-04-16 1985-11-01 Shionogi & Co Ltd Antibiotic do-248-a and do-248-b and preparation thereof
US4992365A (en) * 1984-04-23 1991-02-12 Hyman Edward S Method of detecting bacteria in urine
GB8426463D0 (en) * 1984-10-19 1984-11-28 Technology Licence Co Ltd Monoclonal antibodies
EP0206625B1 (en) * 1985-06-13 1992-09-30 Barry James Dr. Marshall Compositions for the treatment of gastrointestinal disorders
US4950589A (en) * 1987-08-10 1990-08-21 Akzo N.V. Genus-specific listeria antigen identified by monoclonal antibodies
DE3889417T2 (en) * 1987-10-29 1994-12-01 American Cyanamid Co Method for controlling chronic respiratory disease and necrotic enteritis in birds.
WO1989006968A1 (en) * 1988-02-03 1989-08-10 Xoma Corporation Therapeutic use of anti-t cell immunotoxin for autoimmune diseases
WO1989011543A1 (en) * 1988-05-25 1989-11-30 Hyman Edward S Detecting bacteria in urine of horses
CA1339775C (en) * 1988-06-10 1998-03-24 Shuzo Matsushita Antibody 0.5b to hiv-i gp 120 modified with toxic substance
US4957938A (en) * 1989-06-21 1990-09-18 Abbott Laboratories Nutritional formulation for the treatment of renal disease
RU2005487C1 (en) * 1989-06-26 1994-01-15 Научная фирма "Биосиб" Method for treating bronchopulmonary diseases
JPH03112494A (en) * 1989-09-26 1991-05-14 Takehisa Akiyama Monoclonal antibody, diagnosing reagent and assaying method using the same antibody
JP2534139B2 (en) * 1989-10-09 1996-09-11 株式会社大塚製薬工場 Oral amino acid preparation for renal failure
CA2126757A1 (en) * 1991-12-24 1993-07-08 Stephen Herman Medical uses of trioxolane and diperoxide compounds
DE4201988C2 (en) * 1992-01-25 1994-03-03 Pulverer Gerhard DNA probe to identify Staphylococcus haemolyticus
GB2266526A (en) * 1992-03-17 1993-11-03 Merck & Co Inc Substituted cephalosporin sulfones useful in the treatment of leukemia
US5223285A (en) * 1992-03-31 1993-06-29 Abbott Laboratories Nutritional product for pulmonary patients
ZA932523B (en) * 1992-04-10 1994-10-08 Res Dev Foundation Immunotoxins directed against cd33 related surface antigens
JPH06242115A (en) * 1993-02-12 1994-09-02 Hideo Igarashi Inspection method and inspection kit for a group streptococcus pyrogenic toxin and/or rubefaction toxin
EP0697880B1 (en) * 1993-05-03 2001-08-22 Genentech, Inc. Inhibition of leukocyte adhesion
US5438042B1 (en) * 1993-10-08 1997-08-26 Sandoz Nutrition Ltd Enteral nutritional composition having amino acid profile
WO1995013094A1 (en) * 1993-11-10 1995-05-18 Bristol-Myers Squibb Company Treatment of bacterially-induced inflammatory diseases
KR0139235B1 (en) * 1994-01-29 1998-04-28 조세현 Cement bead composition for orthopaedic surgery and its manufacturing process
WO1995022350A1 (en) * 1994-02-18 1995-08-24 Immuno Aktiengesellschaft Composition and method for preventing and treating inflammation with immunoglobulin a
IT1272290B (en) * 1994-06-20 1997-06-16 Avantgarde Spa SALT OF L-CARNITINE AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT FOR THE TREATMENT OF SKIN DISEASES
HU215443B (en) * 1994-07-25 1999-04-28 Márton Milánkovits Pharmaceutical compositions, first of all vaginal suppositorium, containing more active components with bactericide, fungicide, antiprotozoonic and antiviral combined activity

Also Published As

Publication number Publication date
WO1996025155A1 (en) 1996-08-22
AUPN115095A0 (en) 1995-03-09

Similar Documents

Publication Publication Date Title
AU2124397A (en) Compositions and methods for the treatment and diagnosis of cardiovascular disease
EP0808324A4 (en) Compositions and methods for the treatment and diagnosis of cardiovascular disease
HUP9902068A3 (en) Methods and compositions for the diagnosis and treatment of cancer
AU6974996A (en) Compositions for the treatment of dermatological disorders and methods for their use
AU6406996A (en) Compositions for the treatment and diagnosis of body weight disorders, including obesity
AU1575697A (en) Compositions and methods for the treatment and diagnosis of cancer
AU6328696A (en) Treatment of hemoglobinopathies
AU6858996A (en) Pharmaceutical compositions for the treatment of infectious diseases
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
AU2821295A (en) Compositions and methods for the treatment of tumors
AU5053296A (en) Pharmaceutical agents for the treatment of Alzheimer's disease
AU1831195A (en) Methods and compositions for treatment and diagnosis of alzheimer disease and other disorders
AU6786898A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU6786598A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU4841296A (en) Diagnosis of and compositions and methods for the treatment of disease
AU5526196A (en) Compositions for the treatment of dandruff
AU5699396A (en) Compositions for the treatment of skin conditions
AU2593597A (en) Compositions for the diagnosis and treatment of chediak-higashi syndrome
AU8580598A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU6786798A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU4670696A (en) Diagnosis of toxicoinfectious clostridiosis
AU6786698A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU1931895A (en) Treatment of graft-versus-host disease
AU8049098A (en) Composition and methods for the treatment of inflammatory diseases
AU6038196A (en) Compositions and methods of treating il-6 associated disease s

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted